Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Rufinamide impurity 5 is a byproduct associated with the synthesis of Rufinamide, which is an anticonvulsant medication. This compound is primarily used in analytical chemistry and pharmaceutical research to assess the purity and stability of Rufinamide formulations. Its presence can provide insights into the synthesis process and contribute to improving the quality control measures in drug development. -
Drug Impurity
Roxithromycin impurity 5, also known as N-Demethylroxithromycin, is an impurity associated with the antibiotic Roxithromycin. This compound is primarily used in the pharmaceutical industry to study the quality and stability of Roxithromycin formulations. Its presence serves as a point of reference for the identification and quantification of related impurities, contributing to the assessment of drug purity and efficacy in research applications. -
Drug Impurity
Rivastigmine impurity 3 is a known impurity of the acetylcholinesterase inhibitor, Rivastigmine. This compound is utilized in quality control and analytical chemistry to assess the purity of Rivastigmine formulations. Its presence can significantly impact the safety and efficacy profiles of pharmaceutical products, making it relevant for regulatory compliance and drug development studies. -
Drug Impurity
Cetirizine impurity D hydrochloride is a known impurity associated with Cetirizine D hydrochloride. It is commonly utilized in pharmaceutical research to assess the purity and quality of cetirizine formulations. Analyzing this impurity is essential for ensuring compliance with regulatory standards and for the development of safe and effective drug products. -
Drug Impurity
Abacavir impurity 3 is a drug impurity associated with the antiretroviral agent Abacavir, commonly used in the treatment of HIV. This compound is essential for quality control and method validation in pharmaceutical research. Abacavir impurity 3 serves as a critical reference standard for assessing the purity and stability of abacavir formulations, aiding in the development of safe and effective medications. -
Drug Impurity
Pentoxifylline impurity 1 is a known impurity of Pentoxifylline, a xanthine derivative that primarily targets phosphodiesterase enzymes. This compound is relevant for analytical studies in drug formulation and quality control, providing insight into the purity and stability of Pentoxifylline preparations. It is often utilized in research focusing on drug metabolism, stability testing, and pharmacokinetic profiling. -
Drug Impurity
Cinacalcet impurity 3 is a recognized impurity associated with the drug Cinacalcet, a calcimimetic agent that acts primarily on the calcium-sensing receptor (CaSR). This compound is essential for understanding the purity and stability of Cinacalcet formulations, providing valuable insights in drug development and quality control processes. Its characterization plays a critical role in assessing the safety and efficacy of therapeutic products. -
Drug Impurity
Atenolol impurity 4 is a known impurity associated with Atenolol, a beta-adrenergic antagonist. This compound may be utilized for analytical and quality control purposes in drug development, particularly in the evaluation of Atenolol formulations. Its presence and quantification are essential for ensuring the safety and efficacy of pharmaceutical products containing Atenolol. -
Drug Impurity
Donepezil impurity 6 hydrochloride is a known impurity of the acetylcholinesterase inhibitor Donepezil hydrochloride. This compound is critical in the analysis of drug purity and assists in the characterization of donepezil formulations during research and development. Its presence is essential for quality control and safety assessments in the pharmaceutical industry. -
Drug Intermediate
Bengamin hydrochloride, also known as 4-(Aminomethyl)phenol hydrochloride, serves as a crucial drug intermediate in the synthesis of benzylguanidine derivatives. This compound exhibits notable antibacterial activity, making it valuable for various pharmaceutical research applications. Its role in the development of therapeutic agents underlines its significance in medicinal chemistry. -
Drug Impurity
Candesartan impurity 5 is a known impurity associated with the angiotensin II receptor blocker Candesartan. Its characterization is essential for quality control and compliance in pharmaceutical development. This compound is primarily utilized in analytical studies to evaluate the purity of Candesartan formulations and to ensure adherence to regulatory standards in drug manufacturing. -
Drug Impurity
Rosuvastatin impurity 6 is a known impurity associated with the cholesterol-lowering agent Rosuvastatin. It is primarily utilized in analytical research for the characterization and quantification of pharmaceutical formulations. This compound is essential for ensuring the purity and quality of Rosuvastatin in drug development and quality control processes. -
Drug Impurity
Simvastatin impurity 12 is a chemical byproduct associated with Simvastatin. This compound is utilized in pharmaceutical research to evaluate the purity and quality of Simvastatin formulations. Its presence is critical for assessing the stability and safety profiles of lipid-lowering therapies in drug development and regulatory compliance. -
Drug Impurity
Clindamycin palmitate impurity 2, also known as Clindamycin myristate, is a recognized drug impurity associated with the antibiotic clindamycin. This compound is important for research applications focusing on drug formulation and analysis of pharmaceutical products. Its study assists in understanding the implications of impurities on drug efficacy and safety profiles. -
Drug Impurity
Simvastatin impurity 9 is a known impurity associated with the cholesterol-lowering agent Simvastatin. It serves as a critical reference standard for analytical chemistry, particularly in the assessment of drug purity and stability. This compound is utilized in pharmaceutical research to ensure compliance with regulatory guidelines and to investigate the potential effects of impurities on drug efficacy and safety. -
Drug Impurity
Hydrocortisone impurity 8 is a known impurity related to Hydrocortisone, primarily analyzed for its impact on drug formulation and quality. This compound serves as a critical reference standard for assessing the purity of Hydrocortisone in pharmaceutical studies. Its detection and quantification are essential for ensuring the safety and efficacy of corticosteroid-based therapies in research and development settings. -
Drug Impurity
Itraconazole impurity 1 is a known impurity of the antifungal agent Itraconazole. This compound is essential for investigating potential effects on drug formulation integrity and safety profiles. It serves as a critical component for analytical chemistry applications, particularly in quality control and stability testing of pharmaceutical formulations containing Itraconazole. -
Drug Impurity
Fluphenazine impurity 1 is a chemical impurity derived from Fluphenazine. This compound is relevant in studies concerning drug formulation and stability, as well as in the assessment of pharmaceutical quality and safety. Research involving Fluphenazine impurity 1 can provide insight into metabolite profiling and the identification of potential side effects associated with Fluphenazine. -
Drug Impurity
Dabigatran impurity 43 is a known impurity associated with Dabigatran, an oral direct thrombin inhibitor. This compound is utilized in the pharmaceutical analysis of Dabigatran to assess drug quality and safety in research and development. Its characterization is essential for understanding the pharmacological properties and potential side effects of the primary drug compound. -
Drug Intermediate
(R)-Methyl 2-(3-oxocyclopentyl)acetate serves as a chiral organic compound primarily utilized as a drug intermediate in pharmaceutical synthesis. Its unique structure allows for the introduction of cyclopentane motifs into drug candidates, facilitating the development of novel therapeutic agents. This compound is relevant for research applications focusing on medicinal chemistry and the design of biologically active molecules. -
Drug Impurity
Afatinib impurity 33 is a chemical byproduct associated with the synthesis of Afatinib, an irreversible inhibitor of the epidermal growth factor receptor (EGFR). This impurity serves as a reference standard for quality control and methods validation in pharmaceutical research. Its presence is important for the characterization and assessment of Afatinib formulations in drug development and manufacturing processes. -
Drug Impurity
Erythromycin impurity 4 is a known impurity derived from Erythromycin, a macrolide antibiotic that targets bacterial protein synthesis by binding to the 50S ribosomal subunit. This compound is utilized primarily in pharmaceutical research for the characterization and assessment of drug purity in Erythromycin formulations. Its presence may affect the biological efficacy and safety profiles of antibiotic products, making it a crucial component for quality control in drug development. -
Drug Impurity
Aglutin impurity 1 is a characterized impurity associated with the drug Aglutin. It is essential for the assessment of purity and quality in pharmaceutical formulations. This reagent can be used in analytical methods to quantify impurities, ensuring compliance with regulatory standards for drug manufacturing. -
Drug Impurity
Lamivudine Impurity 5 is a defined impurity associated with the antiretroviral drug Lamivudine. This compound is primarily utilized in pharmaceutical research to assess the quality and purity of Lamivudine formulations. It serves as a critical reference standard for analytical methods such as HPLC and is essential for regulatory compliance in the development of HIV therapies. -
Drug Impurity
Thioridazine impurity 1, also known as Thioridazine 5-sulfoxide, is a characterized impurity associated with the antipsychotic agent Thioridazine. This compound is relevant in the context of pharmaceuticals as it may impact the efficacy and safety profile of Thioridazine formulations. Researchers can utilize Thioridazine impurity 1 in the assessment of drug quality, stability studies, and the analysis of therapeutic formulations. -
Drug Impurity
Clindamycin palmitate impurity 10, also known as Clindamycin 4-palmitate, is classified as a drug impurity associated with clindamycin formulations. Its presence can significantly affect the pharmacological profile and stability of drug products. This compound is primarily used in pharmaceutical research to ensure the purity and efficacy of clindamycin formulations, aiding in the analysis and development of safer therapeutic interventions. -
Drug Impurity
Rivaroxaban impurity 26 is a known impurity of the anticoagulant medication Rivaroxaban. This compound serves as a reference standard for the detection and quantification of impurities in pharmaceutical formulations. It is essential for quality control and regulatory compliance in drug development, ensuring the safety and efficacy of Rivaroxaban products. -
Drug Impurity
Moxifloxacin impurity 10, also known as ent-Moxifloxacin hydrochloride, is an identified impurity associated with the antibiotic Moxifloxacin. This compound is primarily utilized in analytical chemistry for quality control and regulatory compliance in pharmaceutical development. Researchers may employ this impurity to study its effects in formulations and to ensure the purity of Moxifloxacin in various applications. -
Drug Impurity
Rosuvastatin impurity 51 is a chemical impurity associated with Rosuvastatin, a statin used for cholesterol management. This impurity may play a role in the evaluation of the drug's purity and quality control in pharmaceutical research. It is relevant for studies focused on assessing the metabolic by-products and potential effects of Rosuvastatin in various biological systems. -
Drug Impurity
Rosuvastatin impurity 48 is a known impurity associated with Rosuvastatin, a statin drug that inhibits HMG-CoA reductase. This impurity can be utilized for analytical and quality control purposes in pharmaceutical research to assess the purity and stability of Rosuvastatin formulations. Its characterization is essential for understanding the compound's behavior in drug development and ensuring regulatory compliance. -
Drug Impurity
Olmesartan impurity 10 is a chemical impurity associated with the antihypertensive agent Olmesartan, primarily affecting its pharmacological profile. This compound can be used in quality control and regulatory compliance studies to assess the purity of Olmesartan formulations. Its characterization is essential for ensuring the safety and efficacy of final drug products in pharmaceutical development. -
Drug Impurity
Naproxen impurity 3 is a chemical impurity associated with Naproxen, a widely used nonsteroidal anti-inflammatory drug (NSAID). This impurity is crucial for assessing the quality and safety of Naproxen in pharmaceutical formulations. It serves as an important reference standard in drug testing and analytical research, aiding researchers in understanding the implications of impurities on drug efficacy and metabolism. -
Drug Impurity
Tenofovir impurity 4 is a minor impurity associated with Tenofovir, an antiretroviral medication. This compound is utilized in pharmaceutical research to assess the quality and stability of Tenofovir formulations. It aids in the evaluation of drug purity and consistency, which is critical for ensuring the safety and efficacy of therapeutic applications. -
Drug Impurity
Apixaban impurity 5 is a chemical impurity associated with the anticoagulant Apixaban. This compound serves as a key reference standard for analytical purposes, particularly in quality control and method validation processes. Its characterization is crucial for ensuring the purity and stability of Apixaban formulations, supporting research into drug efficacy and safety profiles in anticoagulation therapies. -
Drug Impurity
Clarithromycin impurity 14 is a known impurity of the macrolide antibiotic Clarithromycin. Characterized by its potential effects on drug purity, this compound is essential for analytical research and quality control in pharmaceutical formulations. It serves as a reference standard for assessing the presence and concentration of impurities in Clarithromycin products, ensuring compliance with regulatory guidelines. -
Drug Impurity
Pramipexole impurity 4, also known as Pramipexole N6-Ethylamino Analog, is a known impurity associated with the production of Pramipexole. This compound serves as a useful reference standard for analytical methods in drug development and quality control. Its presence can influence the safety and efficacy assessments of Pramipexole formulations, making it vital for research applications focusing on drug purity and stability. -
Drug Impurity
Melatonin impurity 1, also known as N-Acetyl-5-acetoxytryptamine, is an identified impurity of the hormone melatonin. This compound may be utilized in the analysis of melatonin formulations to assess purity and quality. Its presence can provide insights into the synthesis processes and stability profiles of melatonin products in pharmaceutical research and development. -
Drug Impurity
Bupropion impurity 12 is a known impurity of the antidepressant Bupropion. It serves as a reference standard for analyzing drug formulation quality and helps in the identification and quantification of impurities using analytical techniques such as HPLC and mass spectrometry. This impurity can be essential for research applications focused on the safety and efficacy of Bupropion and its metabolites. -
Drug Impurity
Mebendazole impurity 3, also known as 1-Methyl Mebendazole, is a chemical impurity associated with the anthelmintic agent Mebendazole. This compound is significant for quality control and characterization studies in drug formulation processes. Its presence can influence the efficacy and safety profiles of Mebendazole, making it a relevant focus for analytical and pharmacological research. -
Drug Impurity
Betamethasone impurity 2 is a characterized impurity of the corticosteroid Betamethasone, primarily used for research on pharmaceutical quality control. This compound can be used to assess the purity and stability of Betamethasone formulations and is important for understanding the potential impacts of impurities on drug efficacy and safety. Research applications include analytical method development and assessment of drug stability in various formulations. -
Drug Impurity
Leflunomide impurity 1, also known as Leflunomide impurity F, is a chemical reagent identified as an impurity associated with Leflunomide. This compound is primarily utilized in analytical chemistry and pharmaceutical research to ensure the purity and quality of Leflunomide formulations. Its identification and quantification are crucial for compliance with regulatory standards and for understanding the potential effects of impurities in drug metabolism and pharmacokinetics. -
Drug Impurity
Budesonide impurity 86, also known as Budesonide 21-acetate, is a chemical impurity associated with Budesonide. This compound is utilized primarily for analytical and quality control purposes in pharmaceutical research. Its identification and quantification are critical for ensuring the purity and efficacy of Budesonide formulations. Furthermore, it may serve as a reference standard in the evaluation of drug stability and degradation pathways. -
Drug Impurity
Fluocinolone impurity 2 is a specific impurity of the corticosteroid Fluocinolone, primarily identified during the synthesis and formulation processes. This compound is significant in the quality control of Fluocinolone formulations, as the presence of impurities can affect drug efficacy and safety. It is used in pharmaceutical research to assess the purity and stability of corticosteroid products. -
Drug Impurity
Clarithromycin impurity 8, also known as De(cladinosyl) Clarithromycin, is a known impurity associated with the antibiotic Clarithromycin. This compound serves as a critical reference standard for quality control and analytical testing in pharmaceutical research. Its characterization and quantification are essential for ensuring the safety and efficacy of Clarithromycin formulations in pharmaceutical development and compliance testing. -
Drug Impurity
Quetiapine impurity 17 is a known impurity associated with the antipsychotic drug Quetiapine. It is primarily utilized in pharmaceutical research to evaluate the purity and stability of Quetiapine formulations. This compound can assist in the development of analytical methods and quality control processes within drug manufacturing, ensuring compliance with regulatory standards. -
Drug Impurity
Sertraline impurity 12 is a chemical impurity associated with the selective serotonin reuptake inhibitor Sertraline. This compound is utilized primarily in pharmacological studies to assess the purity and quality of Sertraline formulations. It serves as a reference standard in regulatory testing and is essential for understanding the compound's stability and potential effects on efficacy and safety profiles. -
Drug Impurity
Chlorthalidone impurity 8 is a known impurity associated with Chlorthalidone, a thiazide diuretic. This compound is important for analytical chemistry applications, particularly for the characterization and quality control of chlorthalidone formulations. Monitoring impurities such as Chlorthalidone impurity 8 is essential for ensuring the safety and efficacy of pharmaceutical products in compliance with regulatory standards. -
Drug Impurity
Methyl 4-ethoxy-3-oxobutanoate is a drug impurity that may arise during the synthesis of various pharmaceuticals. This compound can serve as a marker for assessing synthesis-related quality control and purity analysis in drug development processes. Its presence can influence the efficacy and safety profiles of therapeutic agents, making it significant for researchers focused on drug formulation and optimization. -
Drug Impurity
Apixaban impurity 45, also known as Apixaban Dehydro impurity, is a recognized impurity associated with the anticoagulant Apixaban. Its characterization is crucial for ensuring the quality and stability of Apixaban formulations. This compound may be utilized in pharmaceutical research to assess the purity and safety profiles of Apixaban and to understand the degradation pathways of the drug. -
Drug Impurity
Brimonidine impurity 4 is a chemical impurity associated with Brimonidine. It is primarily relevant in the characterization and quality control of Brimonidine formulations. This impurity serves as a critical reference standard for analytical methods aimed at ensuring the safety and efficacy of pharmaceutical products containing Brimonidine. Its study aids in understanding the purity profile and stability of the drug.
